The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women With Isolated Hypercholesterolemia
Cardiovascular Therapeutics - United Kingdom
doi 10.1111/1755-5922.12143
Full Text
Open PDFAbstract
Available in full text
Date
September 11, 2015
Authors
Publisher
Wiley